These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12441229)

  • 21. Protective effects of equine herpesvirus-1 (EHV-1) glycoprotein B in a murine model of EHV-1-induced abortion.
    Kukreja A; Walker C; Fitzmaurice T; Awan A; Love DN; Whalley JM; Field HJ
    Vet Microbiol; 1998 Aug; 62(4):303-11. PubMed ID: 9791876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relevance of infection with equine herpesvirus 1 (EHV-1) in a German thoroughbred stud: vaccination, abortion and diagnosis].
    Schröer U; Lange A; Glatzel P; Ludwig H; Borchers K
    Berl Munch Tierarztl Wochenschr; 2000 Feb; 113(2):53-9. PubMed ID: 10726362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strain impact on equine herpesvirus type 1 (EHV-1) abortion models: viral loads in fetal and placental tissues and foals.
    Gardiner DW; Lunn DP; Goehring LS; Chiang YW; Cook C; Osterrieder N; McCue P; Del Piero F; Hussey SB; Hussey GS
    Vaccine; 2012 Oct; 30(46):6564-72. PubMed ID: 22944628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
    Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of the molecular detection of vaccine-derived equine herpesvirus type 1 in blood and nasal secretions from horses following intramuscular vaccination.
    Pusterla N; Chaney KP; Maes R; Wise AG; Holland R; Schott HC
    J Vet Diagn Invest; 2007 May; 19(3):290-3. PubMed ID: 17459860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.
    Van de Walle GR; May MA; Peters ST; Metzger SM; Rosas CT; Osterrieder N
    Vaccine; 2010 Jan; 28(4):1048-55. PubMed ID: 19897066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB; Wagner B; Flaminio MJ; Sussman KH; Metzger SM; Holland R; Osterrieder N
    Vaccine; 2006 Apr; 24(17):3636-45. PubMed ID: 16513225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination of foals and pregnant mares with Duvaxyn EHV1, 4 vaccine.
    Studdert MJ
    Vaccine; 2002 Jan; 20(7-8):992. PubMed ID: 11803056
    [No Abstract]   [Full Text] [Related]  

  • 30. Control of EHV-1 viremia and nasal shedding by commercial vaccines.
    Goehring LS; Wagner B; Bigbie R; Hussey SB; Rao S; Morley PS; Lunn DP
    Vaccine; 2010 Jul; 28(32):5203-11. PubMed ID: 20538091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological correlates of vaccination and infection for equine herpesvirus 1.
    Goodman LB; Wimer C; Dubovi EJ; Gold C; Wagner B
    Clin Vaccine Immunol; 2012 Feb; 19(2):235-41. PubMed ID: 22205656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Equine herpesvirus 1 infection in mares vaccinated with a live-virus rhinopneumonitis vaccine attenuated in cell culture.
    Eaglesome MD; Henry JN; McKnight JD
    Can Vet J; 1979 May; 20(5):145-7. PubMed ID: 226261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abortion of virologically negative foetuses following experimental challenge of pregnant pony mares with equid herpesvirus 1.
    Smith KC; Whitwell KE; Binns MM; Dolby CA; Hannant D; Mumford JA
    Equine Vet J; 1992 Jul; 24(4):256-9. PubMed ID: 1323457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EHV-1 and EHV-4 infection in vaccinated mares and their foals.
    Foote CE; Love DN; Gilkerson JR; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):41-6. PubMed ID: 16513181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Foetal and neonatal foal losses on equine herpesvirus type 1(EHV-1) infected farms before and after EHV-1 vaccination was introduced.
    Frymus T; Kita J; Woyciechowska S; Ganowicz M
    Pol Arch Weter; 1986; 26(3-4):7-14. PubMed ID: 2830601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preventative vaccination against EHV (equine herpesvirus) abortion].
    Becker W
    Tierarztl Prax; 1988; 16(1):61-3. PubMed ID: 2835828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens.
    Breathnach CC; Yeargan MR; Sheoran AS; Allen GP
    Equine Vet J; 2001 Nov; 33(7):651-7. PubMed ID: 11770985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
    Kydd JH; Townsend HG; Hannant D
    Vet Immunol Immunopathol; 2006 May; 111(1-2):15-30. PubMed ID: 16476492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR; Studdert MJ
    Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody and cellular immune responses of naïve mares to repeated vaccination with an inactivated equine herpesvirus vaccine.
    Wagner B; Goodman LB; Babasyan S; Freer H; Torsteinsdóttir S; Svansson V; Björnsdóttir S; Perkins GA
    Vaccine; 2015 Oct; 33(42):5588-5597. PubMed ID: 26384446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.